These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4230535)

  • 21. Cytotoxic activity relative to 4-hydroxycyclophosphamide and phosphoramide mustard concentrations in the plasma of cyclophosphamide-treated rats.
    Powers JF; Sladek NE
    Cancer Res; 1983 Mar; 43(3):1101-6. PubMed ID: 6825082
    [No Abstract]   [Full Text] [Related]  

  • 22. [Comparative studies on the effectiveness of various cytostatics and radiation therapy of experimental tumors in a sample experiment with special regard to telegammatherapy with cobalt60. Survival experiments and cures after the administration of cyclophosphamide ester, triethyleneiminebenzoquinone and radiation separately and in various combinations with Yoshida sarcoma, carcinoma Walker and Jensen sarcoma in albino rats].
    Schneider R
    Strahlentherapie Sonderb; 1965; 61():367-72. PubMed ID: 5827135
    [No Abstract]   [Full Text] [Related]  

  • 23. [A study of the antitumor effectiveness of endoxan when administered in various ways].
    Zaitseva LA; Syrkin AB
    Vopr Onkol; 1969; 15(11):99-101. PubMed ID: 5368849
    [No Abstract]   [Full Text] [Related]  

  • 24. [Action of chemical preparations on transplantable uterine sarcomas in CBA strain mice].
    Bazlova LS; Turusov VS; Bazikian GK
    Akush Ginekol (Mosk); 1980 Mar; (3):57-8. PubMed ID: 7377505
    [No Abstract]   [Full Text] [Related]  

  • 25. Induction of sarcoma of the liver in the rat with methylcholanthrene and benzpyrene.
    EISEN MJ
    Cancer Res; 1946 Aug; 6(8):421-5. PubMed ID: 20992409
    [No Abstract]   [Full Text] [Related]  

  • 26. The pathological effects of the intraperitoneal injection of 3:4-benzpyrene into rats and mice.
    PAYNE S
    Br J Cancer; 1958 Mar; 12(1):65-74. PubMed ID: 13536216
    [No Abstract]   [Full Text] [Related]  

  • 27. [Accelerated development of an induced soft tissue sarcoma in hypokinesia].
    Makarov MA; Cherkasskiĭ LA
    Vopr Onkol; 1983; 29(2):96-9. PubMed ID: 6404057
    [No Abstract]   [Full Text] [Related]  

  • 28. Augmentation of antitumor efficacy by the combination of recombinant tumor necrosis factor and chemotherapeutic agents in vivo.
    Krosnick JA; Mulé JJ; McIntosh JK; Rosenberg SA
    Cancer Res; 1989 Jul; 49(14):3729-33. PubMed ID: 2736513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Extract of Eleutherococcus senticosus maxim and the therapeutic activity of cyclophosphane, ethymidine, and benzo-TEPA].
    Monakhov BV
    Vopr Onkol; 1967; 13(8):94-7. PubMed ID: 5601555
    [No Abstract]   [Full Text] [Related]  

  • 30. [The protective effect of AET, cystamine and cystaphos when using lethal doses of antineoplastic drugs].
    Larionov LF; Spasskaia IG
    Vopr Onkol; 1968; 14(12):33-9. PubMed ID: 5714181
    [No Abstract]   [Full Text] [Related]  

  • 31. Failure to produce tumours in cattle with 20-methylcholanthrene and 3,4-benzpyrene.
    Datta SP; Ghose T
    Experientia; 1970 Jan; 26(1):78-9. PubMed ID: 5412307
    [No Abstract]   [Full Text] [Related]  

  • 32. [The effect of sodium fluoroacetate and metformin on the antitumor activity of cyclophosphamide on the autochthonous mice sarcoma model].
    Anikin IV; Goncharov NV; Tyndyk ML; Voĭshenko NG; Pliss GB; Zabezhinskiĭ MA; Popovich IG; Anisimov VN
    Vopr Onkol; 2014; 60(4):514-6. PubMed ID: 25552075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Study of the blastomogenicity of the products from the light-initiated oxidation of benz(alpha) pyrene].
    Gubergrits MIa; Linnik AB; Paal'me LP; Shabad LM
    Vopr Onkol; 1974; 20(1):77-80. PubMed ID: 4439767
    [No Abstract]   [Full Text] [Related]  

  • 34. [Model studies on postoperative prevention of metastases by cytostatics].
    Kallenbach H
    Med Klin; 1966 Jul; 61(27):1078-9. PubMed ID: 5995186
    [No Abstract]   [Full Text] [Related]  

  • 35. [On the suitability of 2 isologous tumor-host systems for chemotherapeutic studies].
    Horn KH; Siewert R; Madry I
    Arch Geschwulstforsch; 1967; 29(4):324-30. PubMed ID: 4298570
    [No Abstract]   [Full Text] [Related]  

  • 36. [Therapeutic attempt with clostridium butyricum spores and cyclophosphamide in Jensen's sarcoma of the rat].
    Kretschmer H; Ludewig R; Hambsch K
    Arch Geschwulstforsch; 1972; 40(4):335-41. PubMed ID: 4650820
    [No Abstract]   [Full Text] [Related]  

  • 37. Chemotherapeutic response of epithelial tumors produced by primary implantation of a nonproducer line of murine sarcoma virus-transformed BALB 3T3 cells.
    Ikawa Y; Brescia T; Johnson RK; Goldin A
    Cancer Chemother Rep; 1973 Apr; 57(2):149-58. PubMed ID: 4126380
    [No Abstract]   [Full Text] [Related]  

  • 38. Factors determining cell killing by chemotherapeutic agents in vivo. I. Cyclophosphamide.
    van Putten LM; Lelieveld P
    Eur J Cancer (1965); 1970 Aug; 6(4):313-21. PubMed ID: 5274344
    [No Abstract]   [Full Text] [Related]  

  • 39. [On negative results in the cell-free transplantation attempts of chemically-induced sarcomas].
    Hoffmann F; Graffi A
    Arch Geschwulstforsch; 1967; 29(4):315-23. PubMed ID: 4299073
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunotherapy and chemotherapy of Moloney sarcoma virus-induced tumors in mice.
    Fefer A
    Cancer Res; 1969 Dec; 29(12):2177-83. PubMed ID: 5369675
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.